vs
COASTAL FINANCIAL CORP（CCB）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
COASTAL FINANCIAL CORP的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.8倍（$138.0M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -5.8%），COASTAL FINANCIAL CORP自由现金流更多（$246.1M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs -3.6%）
富达国民金融是美国财富500强企业，面向房地产与按揭行业提供产权保险及交割服务。2019年，其产权及房地产业务相关年营收约为84.69亿美元，是行业内具有领先地位的金融服务提供商。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
CCB vs PBYI — 直观对比
营收规模更大
CCB
是对方的1.8倍
$75.5M
营收增速更快
PBYI
高出33.5%
-5.8%
自由现金流更多
CCB
多$231.8M
$14.4M
两年增速更快
PBYI
近两年复合增速
-3.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $138.0M | $75.5M |
| 净利润 | — | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | 12.4% | 22.7% |
| 净利率 | — | — |
| 营收同比 | -5.8% | 27.7% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.84 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CCBPBYI
| Q4 25 | $138.0M | $75.5M | ||
| Q3 25 | $144.7M | $54.5M | ||
| Q2 25 | $119.4M | $52.4M | ||
| Q1 25 | $139.5M | $46.0M | ||
| Q4 24 | $146.5M | $59.1M | ||
| Q3 24 | $151.1M | $80.5M | ||
| Q2 24 | $135.3M | $47.1M | ||
| Q1 24 | $148.4M | $43.8M |
净利润CCBPBYI
| Q4 25 | — | — | ||
| Q3 25 | $13.6M | $8.8M | ||
| Q2 25 | $11.0M | $5.9M | ||
| Q1 25 | $9.7M | $3.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $13.5M | $20.3M | ||
| Q2 24 | $11.6M | $-4.5M | ||
| Q1 24 | $6.8M | $-4.8M |
毛利率CCBPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率CCBPBYI
| Q4 25 | 12.4% | 22.7% | ||
| Q3 25 | 12.4% | 17.6% | ||
| Q2 25 | 12.0% | 12.7% | ||
| Q1 25 | 8.4% | 8.7% | ||
| Q4 24 | 11.7% | 22.6% | ||
| Q3 24 | 10.8% | 27.4% | ||
| Q2 24 | 11.1% | -4.6% | ||
| Q1 24 | 5.9% | -5.3% |
净利率CCBPBYI
| Q4 25 | — | — | ||
| Q3 25 | 9.4% | 16.2% | ||
| Q2 25 | 9.2% | 11.2% | ||
| Q1 25 | 7.0% | 6.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | 8.9% | 25.2% | ||
| Q2 24 | 8.6% | -9.6% | ||
| Q1 24 | 4.6% | -11.0% |
每股收益（稀释后）CCBPBYI
| Q4 25 | $0.84 | $0.26 | ||
| Q3 25 | $0.88 | $0.17 | ||
| Q2 25 | $0.71 | $0.12 | ||
| Q1 25 | $0.63 | $0.06 | ||
| Q4 24 | $0.95 | $0.40 | ||
| Q3 24 | $0.97 | $0.41 | ||
| Q2 24 | $0.84 | $-0.09 | ||
| Q1 24 | $0.50 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $491.0M | $130.3M |
| 总资产 | $4.7B | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资CCBPBYI
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | — | $96.8M | ||
| Q1 24 | — | $107.2M |
总债务CCBPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益CCBPBYI
| Q4 25 | $491.0M | $130.3M | ||
| Q3 25 | $475.3M | $115.3M | ||
| Q2 25 | $461.7M | $104.7M | ||
| Q1 25 | $449.9M | $97.1M | ||
| Q4 24 | $438.7M | $92.1M | ||
| Q3 24 | $331.9M | $71.1M | ||
| Q2 24 | $316.7M | $48.5M | ||
| Q1 24 | $303.7M | $51.0M |
总资产CCBPBYI
| Q4 25 | $4.7B | $216.3M | ||
| Q3 25 | $4.6B | $202.9M | ||
| Q2 25 | $4.5B | $194.9M | ||
| Q1 25 | $4.3B | $196.2M | ||
| Q4 24 | $4.1B | $213.3M | ||
| Q3 24 | $4.1B | $220.7M | ||
| Q2 24 | $4.0B | $205.0M | ||
| Q1 24 | $3.9B | $214.1M |
负债/权益比CCBPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $254.6M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $246.1M | $14.4M |
| 自由现金流率自由现金流/营收 | 178.3% | 19.1% |
| 资本支出强度资本支出/营收 | 6.1% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $436.4M | $41.7M |
8季度趋势，按日历期对齐
经营现金流CCBPBYI
| Q4 25 | $254.6M | $14.4M | ||
| Q3 25 | $59.0M | $9.7M | ||
| Q2 25 | $66.0M | $14.1M | ||
| Q1 25 | $71.7M | $3.6M | ||
| Q4 24 | $259.8M | $15.6M | ||
| Q3 24 | $62.6M | $11.0M | ||
| Q2 24 | $72.1M | $1.0M | ||
| Q1 24 | $56.8M | $11.2M |
自由现金流CCBPBYI
| Q4 25 | $246.1M | $14.4M | ||
| Q3 25 | $57.4M | $9.7M | ||
| Q2 25 | $64.0M | $14.1M | ||
| Q1 25 | $68.9M | $3.6M | ||
| Q4 24 | $249.9M | $15.6M | ||
| Q3 24 | $60.2M | $11.0M | ||
| Q2 24 | $69.5M | $1.0M | ||
| Q1 24 | $55.0M | — |
自由现金流率CCBPBYI
| Q4 25 | 178.3% | 19.1% | ||
| Q3 25 | 39.7% | 17.7% | ||
| Q2 25 | 53.6% | 26.8% | ||
| Q1 25 | 49.4% | 7.7% | ||
| Q4 24 | 170.6% | 26.4% | ||
| Q3 24 | 39.8% | 13.7% | ||
| Q2 24 | 51.3% | 2.1% | ||
| Q1 24 | 37.1% | — |
资本支出强度CCBPBYI
| Q4 25 | 6.1% | 0.0% | ||
| Q3 25 | 1.2% | 0.0% | ||
| Q2 25 | 1.7% | 0.0% | ||
| Q1 25 | 2.0% | 0.1% | ||
| Q4 24 | 6.8% | 0.0% | ||
| Q3 24 | 1.6% | 0.0% | ||
| Q2 24 | 1.9% | 0.0% | ||
| Q1 24 | 1.2% | 0.0% |
现金转化率CCBPBYI
| Q4 25 | — | — | ||
| Q3 25 | 4.34× | 1.10× | ||
| Q2 25 | 5.99× | 2.41× | ||
| Q1 25 | 7.37× | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | 4.65× | 0.54× | ||
| Q2 24 | 6.22× | — | ||
| Q1 24 | 8.35× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CCB
| Other | $74.7M | 54% |
| Baa S Credit Enhancements | $47.3M | 34% |
| Baa S Program Income | $8.4M | 6% |
| Transaction Fees | $4.9M | 4% |
| Servicing And Other Baa S Fees | $1.6M | 1% |
| Baa S Fraud Enhancements | $1.1M | 1% |
PBYI
暂无分部数据
